Abstract
Warfarin and acenocoumarol are commonly prescribed oral anticoagulant drugs that are used in the prevention and treatment of thromboembolic disorders across the world. Although both these drugs act by a similar mechanism, there are significant differences between them, especially in terms of their half-lives, and more importantly, in their variability in response pharmacogenetically. This case report highlights an instance wherein warfarin proved to provide a much more stable anticoagulant cover, as compared to that provided by acenocoumarol.
| Original language | English |
|---|---|
| Pages (from-to) | 4-5 |
| Number of pages | 2 |
| Journal | Asian Journal of Pharmaceutical and Clinical Research |
| Volume | 9 |
| Issue number | 2 |
| Publication status | Published - 01-03-2016 |
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmaceutical Science
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Acenocoumarol or warfarin: Which is the clinician’s ally?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver